Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China flag China · Delayed Price · Currency is CNY
3.300
+0.120 (3.77%)
Apr 29, 2026, 3:04 PM CST

SHE:002390 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
6,2586,1068,6298,5609,13614,423
Market Cap Growth
-11.29%-29.23%0.81%-6.31%-36.66%7.39%
Enterprise Value
5,8235,8948,8208,9329,84115,454
Last Close Price
3.303.224.474.264.466.95
PE Ratio
52.0550.7785.1129.8040.7252.86
Forward PE
-26.3326.3326.3329.3529.35
PS Ratio
1.111.091.431.331.442.23
PB Ratio
0.890.871.231.201.292.11
P/TBV Ratio
1.041.011.461.411.522.49
P/FCF Ratio
9.679.4416.9213.0721.1570.63
P/OCF Ratio
8.548.3413.5910.8315.4631.49
EV/Sales Ratio
1.041.051.461.381.552.39
EV/EBITDA Ratio
10.5310.9117.9614.4117.3320.14
EV/EBIT Ratio
16.9817.1931.1822.8429.5729.24
EV/FCF Ratio
9.009.1117.2913.6422.7875.68
Debt / Equity Ratio
0.060.060.110.120.200.21
Debt / EBITDA Ratio
0.780.781.581.332.421.82
Debt / FCF Ratio
0.670.671.541.283.226.93
Net Debt / Equity Ratio
-0.10-0.10-0.030.000.070.12
Net Debt / EBITDA Ratio
-1.26-1.26-0.460.050.871.03
Net Debt / FCF Ratio
-1.06-1.06-0.450.051.143.87
Asset Turnover
0.640.640.660.680.650.67
Inventory Turnover
4.724.724.855.155.225.76
Quick Ratio
2.622.622.232.021.651.56
Current Ratio
3.313.312.912.632.162.02
Return on Equity (ROE)
2.73%2.73%2.20%4.98%3.86%6.23%
Return on Assets (ROA)
2.43%2.43%1.93%2.57%2.14%3.43%
Return on Invested Capital (ROIC)
4.44%4.35%3.40%4.74%3.75%6.51%
Return on Capital Employed (ROCE)
4.80%4.80%3.90%5.40%4.70%7.70%
Earnings Yield
1.92%1.97%1.18%3.36%2.46%1.89%
FCF Yield
10.34%10.60%5.91%7.65%4.73%1.42%
Dividend Yield
1.89%-1.34%1.41%1.35%0.86%
Payout Ratio
108.76%108.76%189.67%55.09%75.03%84.41%
Buyback Yield / Dilution
0.26%6.43%-5.89%-2.41%-2.79%-15.32%
Total Shareholder Return
2.15%6.43%-4.55%-1.00%-1.44%-14.46%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.